GALT Galectin Therapeutics Inc.
$3.90
Galectin Therapeutics Inc. (GALT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran in line with GALT's own trailing one-year pace, with 65% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
2 sellers in the last 90 days
Insiders buying
2
6 transactions
Insiders selling
5
69 transactions
Purchases
$64.6K
18,200 shares
Sales
$7.0M
1,284,674 shares
Net activity
-$6.9M
purchases less sales
How much of that selling was preplanned? 65% planned / 35% discretionary
10b5-1 plan sales
$4.6M
61 transactions · 851,924 shares
Discretionary sales
$2.4M
8 transactions · 432,750 shares
Largest single sale: $756.8K.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
Last open-market purchase: February 6, 2026 , by ELDRED KARY .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 16,250 | $5.13 | $83.3K | None left | |
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 47,467 | $5.04 | $239.2K | None left | |
| Shlevin Harold H. | Director | Sell 10b5-1 | 22,268 | $5.04 | $112.2K | 6,500 −77.4% of holding | |
| Shlevin Harold H. | Director | Sell 10b5-1 | 7,732 | $5.00 | $38.7K | 6,500 −54.3% of holding | |
| Jamil Khurram 2 fills | Chief Medical Officer | Sell 10b5-1 | 4,570 | $5.00 | $22.9K | None left | |
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 7,557 | $3.14 | $23.7K | None left | |
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 568 | $3.10 | $1.8K | None left | |
| ELDRED KARY | Director | Buy | 300 | $2.70 | $810 | 65,682 | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 37,698 | $3.58 | $134.9K | 832,592 −4.3% of holding | |
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 21,446 | $3.65 | $78.2K | None left | |
| CALLICUTT JACK W | Chief Financial Officer | Sell 10b5-1 | 20,354 | $3.67 | $74.7K | 7,614 −72.8% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 27,731 | $3.91 | $108.3K | 870,290 −3.1% of holding | |
| CALLICUTT JACK W | Chief Financial Officer | Sell 10b5-1 | 25,732 | $3.90 | $100.3K | 27,968 −47.9% of holding | |
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 25,499 | $3.90 | $99.4K | 21,446 −54.3% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 18,571 | $4.20 | $77.9K | 898,021 −2% of holding | |
| CALLICUTT JACK W | Chief Financial Officer | Sell 10b5-1 | 13,914 | $4.20 | $58.4K | 53,700 −20.6% of holding | |
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 13,055 | $4.20 | $54.8K | 46,945 −21.8% of holding | |
| Jamil Khurram | Chief Medical Officer | Sell 10b5-1 | 8,125 | $4.07 | $33.1K | None left | |
| FREEMAN KEVIN D 3 fills | Director | Buy | 16,500 | $3.55 | $58.5K | 55,269 | |
| ELDRED KARY 2 fills | Director | Buy | 1,400 | $3.73 | $5.2K | 65,382 | |
| Shlevin Harold H. 2 fills | Director | Sell 10b5-1 | 24,499 | $7.04 | $172.4K | 11,206 −68.6% of holding | |
| Jamil Khurram 3 fills | Chief Medical Officer | Sell 10b5-1 | 19,442 | $7.04 | $136.9K | None left | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 7,829 | $7.06 | $55.2K | 832,592 −0.9% of holding | |
| Sell | 30,681 | $6.66 | $204.3K | 5,614,457 −0.5% of holding | |||
| Shlevin Harold H. | Director | Sell 10b5-1 | 8,417 | $6.30 | $53.0K | 11,206 −42.9% of holding | |
| Shlevin Harold H. | Director | Sell 10b5-1 | 19,793 | $6.27 | $124.2K | 11,206 −63.9% of holding | |
| Shlevin Harold H. | Director | Sell 10b5-1 | 16,790 | $6.27 | $105.2K | 11,206 −60% of holding | |
| Shlevin Harold H. 7 fills | Director | Sell 10b5-1 | 159,000 | $5.98 | $950.1K | 11,206 −93.4% of holding | |
| 2 fills | Sell | 252,069 | $5.73 | $1.4M | 5,682,207 −4.2% of holding | ||
| 2 fills | Sell | 60,000 | $5.47 | $328.2K | 5,802,207 −1% of holding | ||
| CALLICUTT JACK W 2 fills | Chief Financial Officer | Sell 10b5-1 | 46,310 | $6.22 | $288.2K | 7,614 −85.9% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 6,783 | $6.15 | $41.7K | 832,592 −0.8% of holding | |
| CALLICUTT JACK W 3 fills | Chief Financial Officer | Sell 10b5-1 | 31,610 | $6.03 | $190.7K | 7,614 −80.6% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 15,680 | $6.04 | $94.6K | 832,592 −1.8% of holding | |
| Jamil Khurram 4 fills | Chief Medical Officer | Sell 10b5-1 | 121,117 | $5.47 | $662.5K | 4,479 −96.4% of holding | |
| Sell | 40,000 | $5.25 | $210.0K | 5,832,207 −0.7% of holding | |||
| CALLICUTT JACK W 3 fills | Chief Financial Officer | Sell 10b5-1 | 5,291 | $6.03 | $31.9K | 7,614 −41% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 1,867 | $6.03 | $11.3K | 832,592 −0.2% of holding | |
| CALLICUTT JACK W 3 fills | Chief Financial Officer | Sell 10b5-1 | 600 | $6.00 | $3.6K | 7,614 −7.3% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 200 | $6.00 | $1.2K | 832,592 −0% of holding | |
| CALLICUTT JACK W 3 fills | Chief Financial Officer | Sell 10b5-1 | 28,629 | $6.07 | $173.8K | 7,614 −79% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 14,420 | $6.07 | $87.5K | 832,592 −1.7% of holding | |
| CALLICUTT JACK W 3 fills | Chief Financial Officer | Sell 10b5-1 | 3,810 | $6.01 | $22.9K | 7,614 −33.4% of holding | |
| LEWIS JOEL | President and CEO | Sell 10b5-1 | 1,300 | $6.01 | $7.8K | 832,592 −0.2% of holding | |
| 2 fills | Sell | 50,000 | $4.94 | $246.8K | 5,902,207 −0.8% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.